AtriCure PRO135 AtriClip LAA Exclusion System with Preloaded Gillinov-Cosgrove Clip Instruction Manual

: June 12, 2024
: AtriCure

Table of Contents

AtriCure PRO135 AtriClip LAA Exclusion System with Preloaded Gillinov-
SYMBOLS
INSTRUCTIONS FOR USE
DESCRIPTION
ATRICLIP LAA EXCLUSION SYSTEM
PRECAUTIONS
INSTRUCTIONS FOR USE
DISCLAIMER STATEMENTS
Read User Manual Online (PDF format)
Download This Manual (PDF format)

AtriCure PRO135 AtriClip LAA Exclusion System with Preloaded Gillinov-

Cosgrove Clip

AtriCure-PRO135-AtriClip-LAA-Exclusion-System-with-Preloaded-Gillinov-
Cosgrove-Clip-product-img

SYMBOLS

Non-Pyrogenic\de Nicht pyrogen
Indicated MRI-Conditional
Sterilized by Gamma Radiation
Caution
Single Use Only
Follow instructions for use
Caution: Federal Law (US) restricts this device to sale by or on the order of a physician
Manufacturer
Lot Number
Not made with Natural Rubber Latex
Expiration Date
Authorized Representative in the European Community
Do Not Re-Sterilize
Do Not Use if the Package is Damaged
Product complies with the requirements of directive 93/42/EEC

INSTRUCTIONS FOR USE

AtriClip® LAA Exclusion System with preloaded Gillinov-Cosgrove® Clip (PRO135, PRO140, PRO145, PRO150)

DESCRIPTION

The AtriClip LAA Exclusion System contains the Gillinov-Cosgrove LAA Clip (Clip) for open occlusion of the heart’s left atrial appendage (LAA). The Clip is pre-loaded on a disposable Clip applier. The AtriClip LAA Exclusion System with preloaded Gillinov-Cosgrove Clip does not contain natural rubber latex components.

ATRICLIP LAA EXCLUSION SYSTEM

NOMENCLATURE (SEE FIGURE 1)

AtriCure-PRO135-AtriClip-LAA-Exclusion-System-with-Preloaded-Gillinov-
Cosgrove-Clip-fig-1

Handle
Activation Lever
Lever Release Button
Deployment Tab
Articulation Release Button
Shaft
Articulation Joints
Gillinov–Cosgrove Clip
Deployment Loop
Clip Pull Bar

BEFORE USING PRODUCT READ THE FOLLOWING INFORMATION THOROUGHLY

IMPORTANT!
This booklet is designed to assist in using this product. It is not a reference to surgical techniques.
INDICATION FOR USE
The AtriClip LAA Exclusion System is indicated for open occlusion of the heart’s left atrial appendage.
CONTRAINDICATIONS

Do not use this device as a contraceptive tubal occlusion device.
Do not use this device if the patient has a known allergy to Nitinol (nickel titanium alloy).

WARNINGS

Do not attempt to reposition or remove the Clip after deployment. This may result in tissue damage or tearing.
Use this device only as intended.
Do not use on tissue which, in the opinion of the surgeon, would not be able to tolerate conventional suture materials or conventional closure techniques (such as surgical stapling).
Carefully evaluate Clip position, tissue thickness, and tissue width prior to Clip deployment. To determine appropriate Clip size, refer to the Cosgrove-Gillinov Selection Guide Instructions for Use. Failure to correctly size or deploy the Clip may result in:
tissue trauma, dehiscence, tissue tearing, displacement and/or lack of desired homeostasis.
Do not use on a LAA less than 29mm in width and 1.0mm wall thickness.
Do not use on a LAA greater than 50mm when tissue is uncompressed.
Do not use this device if the patient has sensitivity to Nitinol (nickel titanium alloy).

PRECAUTIONS

Read all instructions carefully for the AtriClip LAA Exclusion System. Failure to properly follow instructions may result in improper functioning of the device.
Use of the device should be limited to properly trained and qualified medical personnel.
Note that variations in specific procedures may occur due to individual physician techniques and patient anatomy.
Do not drop or toss the device as this may induce damage to the device. If the device is dropped, do not use. Replace with a new device.
DO NOT RESTERILIZE. The AtriClip LAA Exclusion System is provided STERILE and is intended for SINGLE use only. Resterilization may cause loss of function or injury to patient.
Carefully consider any pre-surgical treatment the patient may have undergone and in corresponding selection of Clip size. Preoperative radiotherapy may result in changes to tissue. These changes may, for example, cause the tissue thickness to exceed the indicated range for the selected Clip size.
Do not modify this instrument. Use of a modified device may result in improper instrument function. AtriCure, Inc. makes no claim or representation as to the performance characteristics of this product if any modifications have been made to the AtriClip LAA Exclusion System.
Do not kink or excessively bend the shaft as this may affect device performance.
Evacuate thrombus from the LAA prior to Clip application as with other conventional LAA occlusion surgical techniques. Evaluating for the presence of thrombus should be done per the surgeon’s discretion and standard of care.
Position and deploy Clip under direct visualization. Poor visualization may result in suboptimal placement.
Take care to minimize manipulation of the LAA and Clip after Clip deployment.
It is recommended that the Clip be deployed in a dry field.
Do not use the Clip in temperatures below 20 °C. Application of the Clip in temperatures below 20 °C may affect device performance.
Do not attempt to articulate the Deployment Loop while in the locked position. Force applied while in the locked position may cause damage to the device.

INSTRUCTIONS FOR USE

Surgeon judgment, with the assistance of the Gillinov-Cosgrove Selection Guide, should determine what size Clip to apply.

CLIP SELECTION

Using the Gillinov-Cosgrove Selection Guide, determine correct selection of the Gillinov-Cosgrove LAA Clip (See Figure 2). Clip sizes are located on the device package.
Clip Size| LAA Size Range
---|---
35 mm| 29 – 35 mm
40 mm| 34 – 40 mm
45 mm| 39 – 45 mm
50 mm| 44 – 50 mm
Using sterile technique, remove the AtriClip LAA Exclusion System from its packaging.
Using the activation lever on the handle, gently open and close the Clip to assure proper function. Caution: Do not open and close the Clip more than 3 times with the activation lever prior to deployment.
ARTICULATION OF END EFFECTOR
By pressing the Articulation Release Button and pulling it backwards (proximal) into the locked position, the Deployment Loop of the AtriClip LAA Exclusion System may be manually articulated up and down and side-to-side from 0° (inline – as supplied) to ±30° relative to the shaft to aid in the proper placement of the Gillinov-Cosgrove LAA Clip to take into account anatomical variations in the patient’s anatomy (See Figure 3).
To lock the End-effector in position, disengage the Articulation Release Button by pushing down, forward and then releasing.
CLIP POSITIONING
Maneuver the AtriClip LAA Exclusion System into the targeted dissection plane (See Figure 4).
Gently open the Clip by squeezing the activation lever.
NOTE: The Clip can be locked in the open position by means of a locking feature in the handle of the device. The lock will engage when the lever is activated and can be disengaged by gently pressing the locking release button.
Orient the Clip applier with pre-loaded Clip at the tip of LAA with the loops at the ends of the Clip pointed away from the LAA.
Gently position the Clip at the base of the LAA (See Figure 5).
Position the Clip in a manner that provides clear visualization of all tissues being accessed.
While the Clip is still affixed to the Deployment Device, ensure that no surrounding structures interfere with or are damaged by the Clip, and that the Clip is placed correctly.
If the Clip is not placed correctly, gently open the Clip and reposition as needed.
DEPLOYMENT
After the Clip is positioned correctly, grasp the Activation Lever and depress the Lever Release Button and slowly release the Activation Lever allowing the Clip to close.
Deploy the Clip by slowly pulling the Deployment Tab at the proximal end of the handle. NOTE: The Deployment Tab with steel cables may be completely removed from the end of the Handle (See Figure 6).
Following Clip deployment carefully squeeze the activation lever to retract the Pull Bar against the Loop of the BOA2 to prevent unintentional tissue snags when removing the deployment loop.
Carefully remove the deployment loop from the LAA leaving the Clip and attachment suture behind (See Figure 7). Caution: After pulling the Deployment Tab, the AtriClip LAA Exclusion System cannot be used to reposition the Clip.
Discard the deployment device after use. Follow local governing ordinances and recycling plans regarding disposal or recycling of device components.

RETURN OF USED PRODUCT

If for any reason this product must be returned to AtriCure, Inc., a return goods authorization (RGA) number is required from AtriCure, Inc., prior to shipping.
If the product has been in contact with blood or body fluids, it must be thoroughly cleaned and disinfected before packing. It should be shipped in either the original carton or an equivalent carton, to prevent damage during shipment; and it should be properly labeled with an RGA number and an indication of the biohazardous nature of the contents of shipment.
Instructions for cleaning and materials, including appropriate shipping containers, proper labeling, and an RGA number may be obtained from AtriCure, Inc.

DISCLAIMER STATEMENTS

Users assume responsibility for approving the acceptable condition of this product before it is used, and for ensuring that the product is only used in the manner described in these instructions for use, including, but not limited to, ensuring that the product is not re-used.
Under no circumstances will AtriCure, Inc. be responsible for any incidental, special or consequential loss, damage, or expense, which is the result of the deliberate misuse or re-use of this product, including any loss, damage, or expense which is related to personal injury or damage to property.

HANDLING INFORMATION: GILLINOV- COSGROVE LAA CLIP MRI SAFETY INFORMATION

MR Conditional
Non-clinical testing demonstrated that the AOD1 (Annular Occlusion Device) clip is MR Conditional. A patient with this device can be scanned safely in an MR system immediately after placement under the following conditions:

Static magnetic field of 1.5 Tesla and 3 Tesla, only
Maximum spatial gradient magnetic field of 4,000 gauss/cm (40 T/m)(extrapolated) or less
Maximum MR system reported, whole body averaged specific absorption rate (SAR) of 4 W/kg for 15 minutes of scanning (i.e., per pulse sequence) in the First Level Controlled Operating Mode of operation for the MR system
Under the scan conditions defined for the AOD1 Clip is expected to produce a maximum temperature rise of 2.9 °C after 15 minutes of continuous scanning (i.e., per pulse sequence).

Artifact Information
In non-clinical testing, the image artifact caused by the AOD1 Clip extends approximately 10 mm from the AOD1 Clip when imaged using a gradient echo pulse sequence and a 3 Tesla MR system.

Manufacturer